Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence

Soybean (Glycine max) is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the curre...

Full description

Saved in:
Bibliographic Details
Published in:Journal of microbiology and biotechnology 2023-12, Vol.33 (12), p.1552-1562
Main Authors: Jung Hyun Kang, Zigang Dong, Seung Ho Shin
Format: Article
Language:Korean
Subjects:
meta-analysis
precision medicine
soy isoflavone
Soybean
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1562
container_issue 12
container_start_page 1552
container_title Journal of microbiology and biotechnology
container_volume 33
creator Jung Hyun Kang
Zigang Dong
Seung Ho Shin
description Soybean (Glycine max) is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the current clinical evidence focusing on the benefits and risks of soybean ingredients. In breast, prostate, colorectal, ovarian, and lung cancer, epidemiological studies showed an inverse association between soybean food intake and cancer risks. Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes. Notably, soybean was one of the dietary protein sources that may reduce the risk of breast cancer and T2DM. However, soybean had adverse effects on certain types of drug treatment and caused allergies. In sum, this work provides useful considerations for planning clinical soybean research and selecting dietary protein sources for human health.
format article
fullrecord <record><control><sourceid>kiss_kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO202320443346285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>4064036</kiss_id><sourcerecordid>4064036</sourcerecordid><originalsourceid>FETCH-LOGICAL-k505-2db3279c0bf9f2cd9a3434cec4f253e1d5a728492b60c9b6f1fa2fe6f9796c683</originalsourceid><addsrcrecordid>eNo9jE1Lw0AURYMoWKu_wM1sXAYmbybz4S6GatVKxXYfJpM3-GycSKZU-u9tUVzdyz2He5JNCi1MboyG00Pnhc61gfI8u0jpg3NVgFGTbHWHEQNtExsCWw37Fl1kFNn2HdlsdMf1dURPiYbIXrAjTxFvWcXecEf4feR1T5G869lsRx1Gj5fZWXB9wqu_nGbr-9m6nueL5cNjXS3yTcnLHLpWgLaet8EG8J11Qgrp0csApcCiK50GIy20invbqlAEBwFVsNoqr4yYZje_txtKW2pil_rmqXpeAgcBXEohpAJTHrzrfy81XyN9unHfSK4kF0r8ALu7U2c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence</title><source>Open Access: PubMed Central</source><creator>Jung Hyun Kang ; Zigang Dong ; Seung Ho Shin</creator><creatorcontrib>Jung Hyun Kang ; Zigang Dong ; Seung Ho Shin</creatorcontrib><description>Soybean (Glycine max) is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the current clinical evidence focusing on the benefits and risks of soybean ingredients. In breast, prostate, colorectal, ovarian, and lung cancer, epidemiological studies showed an inverse association between soybean food intake and cancer risks. Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes. Notably, soybean was one of the dietary protein sources that may reduce the risk of breast cancer and T2DM. However, soybean had adverse effects on certain types of drug treatment and caused allergies. In sum, this work provides useful considerations for planning clinical soybean research and selecting dietary protein sources for human health.</description><identifier>ISSN: 1017-7825</identifier><identifier>EISSN: 1738-8872</identifier><language>kor</language><publisher>한국미생물생명공학회</publisher><subject>meta-analysis ; precision medicine ; soy isoflavone ; Soybean</subject><ispartof>Journal of microbiology and biotechnology, 2023-12, Vol.33 (12), p.1552-1562</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885</link.rule.ids></links><search><creatorcontrib>Jung Hyun Kang</creatorcontrib><creatorcontrib>Zigang Dong</creatorcontrib><creatorcontrib>Seung Ho Shin</creatorcontrib><title>Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence</title><title>Journal of microbiology and biotechnology</title><addtitle>Journal of Microbiology and Biotechnology</addtitle><description>Soybean (Glycine max) is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the current clinical evidence focusing on the benefits and risks of soybean ingredients. In breast, prostate, colorectal, ovarian, and lung cancer, epidemiological studies showed an inverse association between soybean food intake and cancer risks. Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes. Notably, soybean was one of the dietary protein sources that may reduce the risk of breast cancer and T2DM. However, soybean had adverse effects on certain types of drug treatment and caused allergies. In sum, this work provides useful considerations for planning clinical soybean research and selecting dietary protein sources for human health.</description><subject>meta-analysis</subject><subject>precision medicine</subject><subject>soy isoflavone</subject><subject>Soybean</subject><issn>1017-7825</issn><issn>1738-8872</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9jE1Lw0AURYMoWKu_wM1sXAYmbybz4S6GatVKxXYfJpM3-GycSKZU-u9tUVzdyz2He5JNCi1MboyG00Pnhc61gfI8u0jpg3NVgFGTbHWHEQNtExsCWw37Fl1kFNn2HdlsdMf1dURPiYbIXrAjTxFvWcXecEf4feR1T5G869lsRx1Gj5fZWXB9wqu_nGbr-9m6nueL5cNjXS3yTcnLHLpWgLaet8EG8J11Qgrp0csApcCiK50GIy20invbqlAEBwFVsNoqr4yYZje_txtKW2pil_rmqXpeAgcBXEohpAJTHrzrfy81XyN9unHfSK4kF0r8ALu7U2c</recordid><startdate>20231231</startdate><enddate>20231231</enddate><creator>Jung Hyun Kang</creator><creator>Zigang Dong</creator><creator>Seung Ho Shin</creator><general>한국미생물생명공학회</general><scope>HZB</scope><scope>Q5X</scope><scope>JDI</scope></search><sort><creationdate>20231231</creationdate><title>Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence</title><author>Jung Hyun Kang ; Zigang Dong ; Seung Ho Shin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-k505-2db3279c0bf9f2cd9a3434cec4f253e1d5a728492b60c9b6f1fa2fe6f9796c683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2023</creationdate><topic>meta-analysis</topic><topic>precision medicine</topic><topic>soy isoflavone</topic><topic>Soybean</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung Hyun Kang</creatorcontrib><creatorcontrib>Zigang Dong</creatorcontrib><creatorcontrib>Seung Ho Shin</creatorcontrib><collection>KISS</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><collection>KoreaScience</collection><jtitle>Journal of microbiology and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung Hyun Kang</au><au>Zigang Dong</au><au>Seung Ho Shin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence</atitle><jtitle>Journal of microbiology and biotechnology</jtitle><addtitle>Journal of Microbiology and Biotechnology</addtitle><date>2023-12-31</date><risdate>2023</risdate><volume>33</volume><issue>12</issue><spage>1552</spage><epage>1562</epage><pages>1552-1562</pages><issn>1017-7825</issn><eissn>1738-8872</eissn><abstract>Soybean (Glycine max) is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the current clinical evidence focusing on the benefits and risks of soybean ingredients. In breast, prostate, colorectal, ovarian, and lung cancer, epidemiological studies showed an inverse association between soybean food intake and cancer risks. Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes. Notably, soybean was one of the dietary protein sources that may reduce the risk of breast cancer and T2DM. However, soybean had adverse effects on certain types of drug treatment and caused allergies. In sum, this work provides useful considerations for planning clinical soybean research and selecting dietary protein sources for human health.</abstract><pub>한국미생물생명공학회</pub><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1017-7825
ispartof Journal of microbiology and biotechnology, 2023-12, Vol.33 (12), p.1552-1562
issn 1017-7825
1738-8872
language kor
recordid cdi_kisti_ndsl_JAKO202320443346285
source Open Access: PubMed Central
subjects meta-analysis
precision medicine
soy isoflavone
Soybean
title Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A33%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss_kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benefits%20of%20Soybean%20in%20the%20Era%20of%20Precision%20Medicine:%20A%20Review%20of%20Clinical%20Evidence&rft.jtitle=Journal%20of%20microbiology%20and%20biotechnology&rft.au=Jung%20Hyun%20Kang&rft.date=2023-12-31&rft.volume=33&rft.issue=12&rft.spage=1552&rft.epage=1562&rft.pages=1552-1562&rft.issn=1017-7825&rft.eissn=1738-8872&rft_id=info:doi/&rft_dat=%3Ckiss_kisti%3E4064036%3C/kiss_kisti%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-k505-2db3279c0bf9f2cd9a3434cec4f253e1d5a728492b60c9b6f1fa2fe6f9796c683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=4064036&rfr_iscdi=true